Home > Insider Trading > Filing (0000908662-15-000276)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
907562	Dyax Corp	DYAX	Services-Commercial Physical & Biological Research (8731)	043053198

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1573163	D. Andrew Ashe	C/O Dyax Corp. 55 Network Drive Burlington MA 01803-2756	General Counsel & Evp	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-08-03	62,320	$2.06	96,447	No	4	M	Direct
Common Stock	Disposition	2015-08-03	62,320	$24.21	34,127	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2015-08-03	62,320	$0.00	62,320	$2.06

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.85, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2.
The options became fully vested as of March 31, 2014.
The options expire on various dates between June 20, 2017 and March 31, 2020.